jorry@lonzeal.com
jorry@lonzeal.com
Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. was founded in 2006. It is a full-industry-chain pharmaceutical enterprise integrating finished dosage forms (FDF), active pharmaceutical ingredients (APIs), and pharmaceutical intermediates. Its R&D, production, and quality systems fully comply with ICH guidelines. Adhering to the corporate philosophy of "Shaping Quality with Professionalism and Concentration" and practicing the mission of "Contributing to Health and Beauty."
Lonzeal has built a world-class industrial platform. The R&D center have been recognized as Hebei Provincial Enterprise Technology Center, Grade A Industrial R&D Institution, and Nucleoside Antiviral Drugs Technology Innovation Center. The testing center is CNAS accredited. Backed by those fully integrated industrial chain and supporting facilities, we have established leading advantages in both cost and technology.
Lonzeal is a High-Tech Enterprise, "Little Giant" enterprise specializing in innovation, and Single Champion Enterprise in Manufacturing in Hebei Province. The company has approved and certificated by major global regulatory authorities, including China NMPA, US FDA, WHO PQ, EU EMA, Brazil ANVISA, Russia MOH, and India DCGI.
Bidder in the China national CDC centralized procurement for consecutive years, the company is a key global supplier of anti-HIV medicines, providing stable and reliable drug to 4 million AIDS patients worldwide every year. Beyond exporting to more than 20 countries worldwide, our products have been successfully selected in China's national CDC centralized procurement for.
